CN114306184B - Preparation method of infant wet tissue with sterilization and moisturizing cores - Google Patents
Preparation method of infant wet tissue with sterilization and moisturizing cores Download PDFInfo
- Publication number
- CN114306184B CN114306184B CN202111649015.7A CN202111649015A CN114306184B CN 114306184 B CN114306184 B CN 114306184B CN 202111649015 A CN202111649015 A CN 202111649015A CN 114306184 B CN114306184 B CN 114306184B
- Authority
- CN
- China
- Prior art keywords
- stirring
- wet tissue
- woven fabric
- sterilizing
- infant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention relates to the technical field of sterilization and moisture preservation tissues, in particular to a preparation method of an infant moisture preservation tissue with a sterilization and moisture preservation core; the preparation method of the infant wet tissue with the sterilizing and moisturizing core provided by the invention has the advantages that the integrity of the cell membrane is damaged by changing the surface tension of the cell membrane of the microorganism, and the growth and metabolism of the microorganism cell are interfered, so that the effect of inhibiting the growth of the microorganism is achieved, in addition, the infant wet tissue with the sterilizing and moisturizing core has the environmental friendliness, the biological inertia and the reaction speed controllability of the reaction, a good foundation is laid for the application of the infant wet tissue in hydrogel, and the infant wet tissue with the sterilizing and moisturizing core has excellent stability.
Description
Technical Field
The invention relates to the technical field of sterilization and moisture preservation tissues, in particular to a preparation method of an infant moisture preservation tissue with a sterilization and moisture preservation core.
Background
Disposable wet wipes generally include a liquid pervious topsheet facing the body of the wearer, a liquid impervious backsheet facing the garment of the wearer, a moisture retaining core disposed between the liquid pervious topsheet and backsheet, and means for retaining the moisture retaining core in a fixed relationship relative to the body of the wearer, the moisture retaining core serving as a liquid retaining region of the wet wipe.
The infant wet tissues are mainly used for cleaning buttocks of infants or wiping faces to prevent diaper rash, tinea milk or skin allergy. The infant wet tissues are generally added with an antibacterial agent to enable the infant wet tissues to have a certain antibacterial function.
CN104523457a provides an antibacterial and anti-inflammatory infant wet wipe, which is formed by immersing non-woven fabrics in wet wipe liquid medicine, wherein the wet wipe liquid medicine comprises the following components in parts by weight: 90-95 parts of RO pure water, 1-3 parts of humectant, 0.3-0.5 part of preservative, 0.5-3.5 parts of antibacterial anti-inflammatory agent, 0.1-2 parts of surfactant and 0.1-1 part of skin care agent; the antibacterial and anti-inflammatory agent is a mixture of chitosan quaternary ammonium salt and polyhydroxy stilbene compounds. The invention also discloses a preparation method of the antibacterial and anti-inflammatory infant wet tissue. The antibacterial and anti-inflammatory infant wet tissue provided by the invention has good antibacterial and anti-inflammatory properties, is high in safety, and does not influence the health of infants.
Alcohol solvents of disposable wet tissues volatilize and are dry to the touch after wiping, further improvement is needed, and the practical polyalkenyl polyether crosslinked acrylic acid polymers in the prior art are not suitable for baby wet tissues due to chemical substances, so that a more environment-friendly hydrogel regulator is needed.
Disclosure of Invention
Aiming at the problems, the invention discloses a preparation method of an infant wet tissue with a sterilizing and moisturizing core, and belongs to the technical field of sterilizing and moisturizing tissues.
The preparation method of the infant wet tissue with the sterilizing and moisturizing core is characterized by comprising the following steps of:
s1: the outer packages of the non-woven fabrics and the inner bags are clear and sterilized so as to be sent to a purification workshop for use.
S2: arrangement of wet towel liquid medicine
The wet tissue liquid medicine comprises the following components:
| sequence number | Chemical name | Mass percent% | CAS number |
| 1 | Chlorophenyl glycolether | 0.01-0.07 | 104-29-0 |
| 2 | Ethylhexyl glycerol | 0.01-0.07 | 70445-33-9 |
| 3 | Aloe extract | 0.01-0.05 | 8001-97-6 |
| 4 | Cetyl pyridinium chloride | 0.01-0.05 | 6004-24-6 |
| 5 | Benzalkonium chloride | 0.006-0.07 | 8001-54-5 |
| 6 | Dipropylene glycol | 0.05-0.3 | 25265-71-8 |
| 7 | Citric acid | 0.05-0.3 | 77-92-9 |
| 8 | Surface active agent | 0.05-0.3 | 9005-64-5 |
| 9 | Xylitol | 0.05-0.3 | 87-99-0 |
| 10 | Vitamins | 0.05-0.3 | 7695-91-2 |
| 11 | Hydrogel modulators | 0.1-0.8％ | -- |
| 12 | Pure water | Allowance of | 7732-18-5 |
| Totals to | 100％ |
Weighing corresponding liquid medicine according to a formula table, and re-weighing to ensure the consistency of the formula; stirring for 1-3 hours; adding pure water, stirring for 3-6 hr to dissolve the medicinal liquid completely, and filtering to remove impurity components;
s3: and (3) cloth feeding: and setting the cutting length of the base cloth according to the product requirement, and adjusting the folding width.
Opening a liquid supply power switch and a stirrer switch in the folding machine electric box; checking the weight, size, humidification uniformity, fuzzing at the cut-off position and other items of the unpacked single-package product according to the specification of the product; loading the non-woven fabric into a machine, and carrying out necessary folding on the non-woven fabric by the machine; when the base cloth is not stable enough in folding or the width of the base cloth is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can be ensured to stably run and the width of the base cloth is not narrowed.
S4: and (3) drug cloth combination soaking:
coating high-fluffiness cotton layer with non-woven fabric, soaking with solution, making into moisturizing core, stirring for 1-3 hr, and packaging to obtain the final product.
More preferably, the preparation method of the hydrogel regulator comprises the following steps:
adding 10-15 parts of dimercapto cross-linking agent, 8-15 parts of ammonium acryloyldimethyl taurate and 2-5 parts of catalyst into 100-200 parts of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
more preferably, the dimercapto crosslinking agent is selected from one of the following: dimercapto polyethylene glycol, dithiothreitol;
more preferably, the catalyst is sodium ethoxide;
more preferably, the reaction condition is stirring reaction for 80-150min at the temperature of 70-80 ℃;
more preferably, the stirring is magnetic stirring, and the stirring speed is 320-480r/min;
more preferably, the stirring temperature of the wet tissue liquid medicine is 20-30 ℃;
more preferably, the vitamin is vitamin E;
more preferably, the surfactant is tween 20.
Reaction mechanism:
ethylhexyl glycerol of the present invention: it can interfere with interfacial tension, making some active ingredients or preservatives more accessible to microbial cells. The integrity of the cell membrane is damaged by changing the surface tension of the cell membrane of the microorganism, and the growth and metabolism of the microorganism cell are interfered, so that the effect of inhibiting the growth of the microorganism is achieved;
xylitol or dipropylene glycol of the present invention is a humectant.
The benzalkonium chloride is an antibacterial and anti-inflammatory agent.
The amino acid humectant or the glycerol is a humectant.
The cetyl pyridine chloride or the chlorphenyl glycine ether and the ethylhexyl glycerol are used as preservatives.
The aloe extract is a skin care agent.
The hydrogel regulator adopts a dimercapto cross-linking agent, and the ammonium acryloyldimethyl taurate undergoes an addition reaction to obtain the hydrogel regulator.
The technical effects are as follows:
the reaction of the invention has environmental friendliness, biological inertia and reaction speed controllability, lays a good foundation for the application of the hydrogel in the application of the hydrogel, and has excellent stability.
Drawings
FIG. 1 is a flow chart of a wet wipe manufacturing process.
Detailed Description
The invention will be described in detail with reference to preferred embodiments, but the practice and protection of the invention is not limited thereto:
example 1
The preparation method of the infant wet tissue with the sterilizing and moisturizing core is characterized by comprising the following steps of:
s1: the outer packages of the non-woven fabrics and the inner bags are clear and sterilized so as to be sent to a purification workshop for use.
S2: arrangement of wet towel liquid medicine
The wet tissue liquid medicine comprises the following components:
| sequence number | Chemical name | Mass kg | CAS number |
| 1 | Chlorophenyl glycolether | 0.03 | 104-29-0 |
| 2 | Ethylhexyl glycerol | 0.02 | 70445-33-9 |
| 3 | Aloe extract | 0.02 | 8001-97-6 |
| 4 | Cetyl pyridinium chloride | 0.01 | 6004-24-6 |
| 5 | Benzalkonium chloride | 0.018 | 8001-54-5 |
| 6 | Dipropylene glycol | 0.12 | 25265-71-8 |
| 7 | Citric acid | 0.18 | 77-92-9 |
| 8 | Surface active agent | 0.20 | 9005-64-5 |
| 9 | Xylitol | 0.08 | 87-99-0 |
| 10 | Vitamins | 0.09 | 7695-91-2 |
| 11 | Hydrogel modulators | 0.3 | -- |
| 12 | Pure water | Allowance of | 7732-18-5 |
| Totals to | 100 |
Weighing corresponding liquid medicine according to a formula table, and re-weighing to ensure the consistency of the formula; stirring for 2 hours; adding pure water, stirring for 3 hr to dissolve the medicinal liquid completely, and filtering to remove impurity components;
s3: and (3) cloth feeding: and setting the cutting length of the base cloth according to the product requirement, and adjusting the folding width.
Opening a liquid supply power switch and a stirrer switch in the folding machine electric box; checking the weight, size, humidification uniformity, fuzzing at the cut-off position and other items of the unpacked single-package product according to the specification of the product; loading the non-woven fabric into a machine, and carrying out necessary folding on the non-woven fabric by the machine; when the base cloth is not stable enough in folding or the width of the base cloth is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can be ensured to stably run and the width of the base cloth is not narrowed.
S4: and (3) drug cloth combination soaking:
coating the high-fluffiness cotton layer with non-woven fabric, soaking with the solution to obtain a moisturizing core, stirring for 2 hours, and packaging to obtain the product.
The preparation method of the hydrogel regulator comprises the following steps:
adding 10g of dimercapto cross-linking agent, 8g of ammonium acryloyldimethyl taurate and 2g of catalyst into 100g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dimercapto polyethylene glycol;
the catalyst is sodium ethoxide;
the reaction condition is stirring reaction for 120min at the temperature of 70 ℃;
the stirring is magnetic stirring, and the stirring rotating speed is 320r/min;
the stirring temperature of the wet tissue liquid medicine is 20 ℃;
the vitamin is vitamin E;
the surfactant is Tween 20.
Example 2
The preparation method of the infant wet tissue with the sterilizing and moisturizing core is characterized by comprising the following steps of:
s1: the outer packages of the non-woven fabrics and the inner bags are clear and sterilized so as to be sent to a purification workshop for use.
S2: arrangement of wet towel liquid medicine
The wet tissue liquid medicine comprises the following components:
| sequence number | Chemical name | Mass kg | CAS number |
| 1 | Chlorophenyl glycolether | 0.05 | 104-29-0 |
| 2 | Ethylhexyl glycerol | 0.02 | 70445-33-9 |
| 3 | Aloe extract | 0.04 | 8001-97-6 |
| 4 | Cetyl pyridinium chloride | 0.03 | 6004-24-6 |
| 5 | Benzalkonium chloride | 0.03 | 8001-54-5 |
| 6 | Dipropylene glycol | 0.10 | 25265-71-8 |
| 7 | Citric acid | 0.05-0.3 | 77-92-9 |
| 8 | Surface active agent | 0.16 | 9005-64-5 |
| 9 | Xylitol | 0.12 | 87-99-0 |
| 10 | Vitamins | 0.20 | 7695-91-2 |
| 11 | Hydrogel modulators | 0.20 | -- |
| 12 | Pure water | Allowance of | 7732-18-5 |
| Totals to | 100 |
Weighing corresponding liquid medicine according to a formula table, and re-weighing to ensure the consistency of the formula; stirring for 2 hours; adding pure water, stirring for 4 hr to dissolve the medicinal liquid completely, and filtering to remove impurity components;
s3: and (3) cloth feeding: and setting the cutting length of the base cloth according to the product requirement, and adjusting the folding width.
Opening a liquid supply power switch and a stirrer switch in the folding machine electric box; checking the weight, size, humidification uniformity, fuzzing at the cut-off position and other items of the unpacked single-package product according to the specification of the product; loading the non-woven fabric into a machine, and carrying out necessary folding on the non-woven fabric by the machine; when the base cloth is not stable enough in folding or the width of the base cloth is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can be ensured to stably run and the width of the base cloth is not narrowed.
S4: and (3) drug cloth combination soaking:
coating the high-fluffiness cotton layer with non-woven fabric, soaking with the solution to obtain a moisturizing core, stirring for 2 hours, and packaging to obtain the product.
The preparation method of the hydrogel regulator comprises the following steps:
adding 11g of dimercapto cross-linking agent, 9g of ammonium enoyl dimethyl taurate and 2g of catalyst into 120g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dimercapto polyethylene glycol;
the catalyst is sodium ethoxide;
the reaction condition is stirring reaction for 100min at the temperature of 72 ℃;
the stirring is magnetic stirring, and the stirring rotating speed is 320r/min;
the stirring temperature of the wet tissue liquid medicine is 20 ℃;
the vitamin is vitamin E;
the surfactant is Tween 20.
Example 3
The preparation method of the infant wet tissue with the sterilizing and moisturizing core is characterized by comprising the following steps of:
s1: the outer packages of the non-woven fabrics and the inner bags are clear and sterilized so as to be sent to a purification workshop for use.
S2: arrangement of wet towel liquid medicine
The wet tissue liquid medicine comprises the following components:
weighing corresponding liquid medicine according to a formula table, and re-weighing to ensure the consistency of the formula; stirring for 3 hours; adding pure water, stirring for 3 hr to dissolve the medicinal liquid completely, and filtering to remove impurity components;
s3: and (3) cloth feeding: and setting the cutting length of the base cloth according to the product requirement, and adjusting the folding width.
Opening a liquid supply power switch and a stirrer switch in the folding machine electric box; checking the weight, size, humidification uniformity, fuzzing at the cut-off position and other items of the unpacked single-package product according to the specification of the product; loading the non-woven fabric into a machine, and carrying out necessary folding on the non-woven fabric by the machine; when the base cloth is not stable enough in folding or the width of the base cloth is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can be ensured to stably run and the width of the base cloth is not narrowed.
S4: and (3) drug cloth combination soaking:
coating the high-fluffiness cotton layer with non-woven fabric, soaking with the solution to obtain a moisturizing core, stirring for 1 hour, and packaging to obtain the product.
More preferably, the preparation method of the hydrogel regulator comprises the following steps:
adding 12g of dimercapto cross-linking agent, 10g of ammonium acryloyldimethyl taurate and 3g of catalyst into 140g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dithiothreitol;
the catalyst is sodium ethoxide;
the reaction condition is stirring reaction for 90min at the temperature of 76 ℃;
the stirring is magnetic stirring, and the stirring rotating speed is 320r/min;
the stirring temperature of the wet tissue liquid medicine is 26 ℃;
the vitamin is vitamin E;
the surfactant is Tween 20.
Example 4
The preparation method of the infant wet tissue with the sterilizing and moisturizing core is characterized by comprising the following steps of:
s1: the outer packages of the non-woven fabrics and the inner bags are clear and sterilized so as to be sent to a purification workshop for use.
S2: arrangement of wet towel liquid medicine
The wet tissue liquid medicine comprises the following components:
weighing corresponding liquid medicine according to a formula table, and re-weighing to ensure the consistency of the formula; stirring for 2 hours; adding pure water, stirring for 4 hr to dissolve the medicinal liquid completely, and filtering to remove impurity components;
s3: and (3) cloth feeding: and setting the cutting length of the base cloth according to the product requirement, and adjusting the folding width.
Opening a liquid supply power switch and a stirrer switch in the folding machine electric box; checking the weight, size, humidification uniformity, fuzzing at the cut-off position and other items of the unpacked single-package product according to the specification of the product; loading the non-woven fabric into a machine, and carrying out necessary folding on the non-woven fabric by the machine; when the base cloth is not stable enough in folding or the width of the base cloth is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can be ensured to stably run and the width of the base cloth is not narrowed.
S4: and (3) drug cloth combination soaking:
coating the high-fluffiness cotton layer with non-woven fabric, soaking with the solution to obtain a moisturizing core, stirring for 3 hours, and packaging to obtain the product.
The preparation method of the hydrogel regulator comprises the following steps:
160g of cosmetic white oil is added with 14g of dimercapto cross-linking agent, 12g of ammonium acryloyldimethyl taurate and 4g of catalyst, and the white oil is distilled off after the reaction is finished, so as to obtain the hydrogel regulator;
the dimercapto cross-linking agent is dithiothreitol;
the catalyst is sodium ethoxide;
the reaction condition is stirring reaction for 130min at the temperature of 76 ℃;
the stirring is magnetic stirring, and the stirring rotating speed is 480r/min;
the stirring temperature of the wet tissue liquid medicine is 26 ℃;
the vitamin is vitamin E;
the surfactant is Tween 20.
Example 5
The preparation method of the infant wet tissue with the sterilizing and moisturizing core is characterized by comprising the following steps of:
s1: the outer packages of the non-woven fabrics and the inner bags are clear and sterilized so as to be sent to a purification workshop for use.
S2: arrangement of wet towel liquid medicine
The wet tissue liquid medicine comprises the following components:
weighing corresponding liquid medicine according to a formula table, and re-weighing to ensure the consistency of the formula; stirring for 3 hours; adding pure water, stirring for 3 hr to dissolve the medicinal liquid completely, and filtering to remove impurity components;
s3: and (3) cloth feeding: and setting the cutting length of the base cloth according to the product requirement, and adjusting the folding width.
Opening a liquid supply power switch and a stirrer switch in the folding machine electric box; checking the weight, size, humidification uniformity, fuzzing at the cut-off position and other items of the unpacked single-package product according to the specification of the product; loading the non-woven fabric into a machine, and carrying out necessary folding on the non-woven fabric by the machine; when the base cloth is not stable enough in folding or the width of the base cloth is obviously narrowed, the tension of the base cloth can be changed by adjusting the tension of the base cloth, so that the base cloth can be ensured to stably run and the width of the base cloth is not narrowed.
S4: and (3) drug cloth combination soaking:
coating the high-fluffiness cotton layer with non-woven fabric, soaking with the solution to obtain a moisturizing core, stirring for 2 hours, and packaging to obtain the product.
The preparation method of the hydrogel regulator comprises the following steps:
adding 12g of dimercapto cross-linking agent, 15g of ammonium acryloyldimethyl taurate and 5g of catalyst into 200g of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto cross-linking agent is dimercapto polyethylene glycol;
the catalyst is sodium ethoxide;
the reaction condition is stirring reaction for 90min at the temperature of 80 ℃;
the stirring is magnetic stirring, and the stirring rotating speed is 480r/min;
the stirring temperature of the wet tissue liquid medicine is 26 ℃;
the vitamin is vitamin E;
the surfactant is Tween 20.
The testing method comprises the following steps:
reference U.S. pharmacopoeia USP-NF microbiological tests of non-sterile products: detecting microbial count; microbiological testing of USP-NF non-sterile products: detection of specific microorganisms.
Table 1 example test results
Claims (4)
1. The preparation method of the infant wet tissue with the sterilizing and moisturizing core comprises the following operation steps:
s1: removing the outer packages of the non-woven fabrics and the inner bags, and sterilizing so as to send the non-woven fabrics and the inner bags into a purification workshop for use;
s2: arrangement of wet towel liquid medicine
The wet tissue liquid medicine comprises the following components:
weighing corresponding medicines according to a formula table, and re-weighing to ensure the consistency of the formula; stirring for 1-3 hours; adding pure water, stirring for 3-6 hr to dissolve the medicine completely, and filtering to remove impurity components;
s3: and (3) cloth feeding: setting the cutting length of the non-woven fabric according to the product requirement, and adjusting the folding width;
opening a liquid supply power switch and a stirrer switch in the folding machine electric box; checking the weight, the size, the humidification uniformity and the fuzzing of cut parts of the unpackaged single-package product according to the specification of the product; loading the non-woven fabric into a machine, and carrying out necessary folding on the non-woven fabric by the machine; when the non-woven fabric is not stable enough in folding or the width of the non-woven fabric is obviously narrowed, the tension of the non-woven fabric is changed by adjusting the tension of the non-woven fabric, so that the non-woven fabric is ensured to stably run and the width of the non-woven fabric is not narrowed;
s4: and (3) drug cloth combination soaking:
coating a high-fluffiness cotton layer with non-woven fabrics, soaking with a medicinal liquid to prepare a moisturizing core, stirring for 1-3 hours, and packaging to obtain a product;
the preparation method of the hydrogel regulator comprises the following steps:
adding 10-15 parts of dimercapto cross-linking agent, 8-15 parts of ammonium acryloyldimethyl taurate and 2-5 parts of catalyst into 100-200 parts of cosmetic white oil, and evaporating the white oil after the reaction is finished to obtain a hydrogel regulator;
the dimercapto crosslinking agent is selected from one of the following substances: dimercapto polyethylene glycol, dithiothreitol;
the catalyst is sodium ethoxide;
the reaction condition is stirring reaction for 80-150min at the temperature of 70-80 ℃;
the stirring is magnetic stirring, and the stirring rotating speed is 320-480r/min.
2. The method for preparing the infant wet tissue with the sterilizing and moisturizing core according to claim 1, wherein the method comprises the following steps: the stirring temperature of the wet tissue liquid medicine is 20-30 ℃.
3. The method for preparing the infant wet tissue with the sterilizing and moisturizing core according to claim 1, wherein the method comprises the following steps: the vitamin is vitamin E.
4. The method for preparing the infant wet tissue with the sterilizing and moisturizing core according to claim 1, wherein the method comprises the following steps: the surfactant is Tween 20.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111649015.7A CN114306184B (en) | 2021-12-30 | 2021-12-30 | Preparation method of infant wet tissue with sterilization and moisturizing cores |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111649015.7A CN114306184B (en) | 2021-12-30 | 2021-12-30 | Preparation method of infant wet tissue with sterilization and moisturizing cores |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114306184A CN114306184A (en) | 2022-04-12 |
| CN114306184B true CN114306184B (en) | 2023-07-25 |
Family
ID=81018687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111649015.7A Active CN114306184B (en) | 2021-12-30 | 2021-12-30 | Preparation method of infant wet tissue with sterilization and moisturizing cores |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114306184B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140068708A (en) * | 2012-11-28 | 2014-06-09 | 한종우 | Sterilized wet tissue and manufacturing mehotd of the same |
| CN104523457A (en) * | 2014-11-13 | 2015-04-22 | 苏州威尔德工贸有限公司 | Antisepsis and anti-inflammation baby wet tissue and preparation method thereof |
| KR20150102578A (en) * | 2014-02-28 | 2015-09-07 | 우일씨앤텍(주) | Antibiotic wet tissue, and manufacturing method thereof |
| CN108066184A (en) * | 2017-12-29 | 2018-05-25 | 武汉芘芘薇莎生物科技有限公司 | A kind of preparation method of baby wipes |
| CN109692145A (en) * | 2019-03-13 | 2019-04-30 | 福建三达节能新材股份有限公司 | A kind of silk non-woven fabric of baby wipes and preparation method thereof |
| CN110742845A (en) * | 2019-11-26 | 2020-02-04 | 苏州东方之宝生物药业有限公司 | Wet tissue and preparation method thereof |
| CN111840182A (en) * | 2020-07-27 | 2020-10-30 | 支允前 | Multifunctional traditional Chinese medicine antibacterial sanitary wet tissue and preparation method thereof |
-
2021
- 2021-12-30 CN CN202111649015.7A patent/CN114306184B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140068708A (en) * | 2012-11-28 | 2014-06-09 | 한종우 | Sterilized wet tissue and manufacturing mehotd of the same |
| KR20150102578A (en) * | 2014-02-28 | 2015-09-07 | 우일씨앤텍(주) | Antibiotic wet tissue, and manufacturing method thereof |
| CN104523457A (en) * | 2014-11-13 | 2015-04-22 | 苏州威尔德工贸有限公司 | Antisepsis and anti-inflammation baby wet tissue and preparation method thereof |
| CN108066184A (en) * | 2017-12-29 | 2018-05-25 | 武汉芘芘薇莎生物科技有限公司 | A kind of preparation method of baby wipes |
| CN109692145A (en) * | 2019-03-13 | 2019-04-30 | 福建三达节能新材股份有限公司 | A kind of silk non-woven fabric of baby wipes and preparation method thereof |
| CN110742845A (en) * | 2019-11-26 | 2020-02-04 | 苏州东方之宝生物药业有限公司 | Wet tissue and preparation method thereof |
| CN111840182A (en) * | 2020-07-27 | 2020-10-30 | 支允前 | Multifunctional traditional Chinese medicine antibacterial sanitary wet tissue and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 婴儿湿巾的发展概述;吴桃桃;;非织造布;16(03);10-12 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114306184A (en) | 2022-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4926355B2 (en) | Articles having movable breathable skin care compositions | |
| EP1061964B2 (en) | Proton donating actives in absorbent articles | |
| KR100476911B1 (en) | Web materials with two or more skin care compositions disposed thereon and articles made therefrom | |
| CN101959509B (en) | Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners | |
| US6107537A (en) | Disposable absorbent articles providing a skin condition benefit | |
| US20060222675A1 (en) | Personal care compositions with color changing indicator | |
| TW299227B (en) | ||
| KR20040070207A (en) | System for skin health of absorbent article wearers | |
| JP2002505916A (en) | Disposable absorbent products having skin care compositions containing enzyme inhibitors | |
| CN101959493A (en) | Moisturizing hand sanitizer | |
| WO2000010500A1 (en) | Absorbent article which maintains or improves skin health | |
| KR101695834B1 (en) | A hydrogel mask pack composition having the increased oxygen penetration and the hydrogel mask pack comprising the same | |
| CN110464658B (en) | Multi-effect eye freeze-dried film and steam eye-shade | |
| CN104352385A (en) | Anti-ageing essence | |
| JP2018504507A (en) | Synthetic surfactant-free finishing agents, sheets with synthetic surfactant-free finishing agents, articles having sheets with synthetic surfactant-free finishing agents, and related methods | |
| CA2311510C (en) | Skin care composition | |
| CN107929104A (en) | A kind of three-in-one wash and maintenance liquid of biology enzyme and preparation method thereof | |
| CN110974717B (en) | Moisturizing baby wet tissue capable of removing dirt and preparation method thereof | |
| CN114306184B (en) | Preparation method of infant wet tissue with sterilization and moisturizing cores | |
| KR20150083872A (en) | Triggerable compositions for two-stage, controlled release of active chemistry | |
| KR20000069286A (en) | Absorbent articles having cuffs with skin care composition disposed thereon | |
| CN113181084A (en) | Skin-care and bacteriostatic coconut fat solvent and preparation method and application thereof | |
| EP2632432B1 (en) | Composition and method for treating wounds | |
| JP2005002008A (en) | Composition having function to prevent contact dermatitis | |
| JP4568892B2 (en) | Finishing method for textile products |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |